[1] |
LIAO Qian, WANG Hanwen, DENG Lingli, OUYANG Fei, YU Chunshui. Borderline tuberculoid leprosy: two cases report[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 683
-684
. |
[2] |
LUO Lingling, CUI Pangen. Update of tumor necrosis factor inhibitor for the treatment of non-psoriatic skin diseases [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 698
-700,704
. |
[3] |
LI Bowei, LI Shuli, YANG Yuqi, ZHANG Weigang, LIU Ling, GAO Tianwen, LI Chunying. Effects of immune microenvironment on the expression of CXCL10 in melanocytes of vitiligo[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(1): 8
-11
. |
[4] |
ZHU Mingming, LIU Kefeng. Efficacy of botulinum toxin type A in the treatment post-herpetic neuralgia[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(8): 473
-474
. |
[5] |
LI Mingfeng, JIANG Juan.. Update of immune mechanism of rosacea[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(11): 690
-692,697
. |
[6] |
ZHANG Xin, HAO Yu-qin . Update of shRNA targeting survivin in the treatment of tumor[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(1): 58
-60
. |
[7] |
GUO Kun, XIAO Shengxiang, GENG Songmei. Expression of Klf4 in the lesions of the patients with psoriasis or eczema[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 394
-396
. |
[8] |
YANG Chuan, JIAN Shunhai, ZHANG Hao, TIAN Lidi, SU Xiaocui, SU Xianzhu, QING Defu. Inverse psoriasis: two cases report[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(2): 103
-105
. |
[9] |
WANG Juan, BAI Li, ZHAO Yijin, BAO Haiping, MI Xiting. Expression of COX-2 and phosphorylated P38 mitogen-activated protein kinase in the lesions of lichen planus[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(4): 208
-210
. |
[10] |
CHEN Mei, MA Huimiao, ZHAO Ruiheng, GUO Xicai, ZHANG Xiaoyan. Drug eruption induced by PD-1 inhibitors misdiagnosed as psoriasis: a case report[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(8): 494
-495
. |
|